175 related articles for article (PubMed ID: 27031095)
21. Regulatory T Cells but Not IL-10 Impair Cell-Mediated Immunity in Human Papillomavirus E7+ Hyperplastic Epithelium.
Bashaw AA; Zhou C; Yu M; Tolley L; Leggatt GR; Frazer IH; Chandra J
J Invest Dermatol; 2021 May; 141(5):1264-1273.e3. PubMed ID: 33129828
[TBL] [Abstract][Full Text] [Related]
22. High Levels of EBV-Encoded RNA 1 (EBER1) Trigger Interferon and Inflammation-Related Genes in Keratinocytes Expressing HPV16 E6/E7.
Aromseree S; Middeldorp JM; Pientong C; van Eijndhoven M; Ramayanti O; Lougheed SM; Pegtel DM; Steenbergen RD; Ekalaksananan T
PLoS One; 2017; 12(1):e0169290. PubMed ID: 28056059
[TBL] [Abstract][Full Text] [Related]
23. DNA vaccine encoding HPV-16 E7 with mutation in L-Y-C-Y-E pRb-binding motif induces potent anti-tumor responses in mice.
Bahrami AA; Ghaemi A; Tabarraei A; Sajadian A; Gorji A; Soleimanjahi H
J Virol Methods; 2014 Sep; 206():12-8. PubMed ID: 24880067
[TBL] [Abstract][Full Text] [Related]
24. T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx.
Hoffmann TK; Arsov C; Schirlau K; Bas M; Friebe-Hoffmann U; Klussmann JP; Scheckenbach K; Balz V; Bier H; Whiteside TL
Int J Cancer; 2006 Apr; 118(8):1984-91. PubMed ID: 16284959
[TBL] [Abstract][Full Text] [Related]
25. NKT cells inhibit antigen-specific effector CD8 T cell induction to skin viral proteins.
Mattarollo SR; Yong M; Gosmann C; Choyce A; Chan D; Leggatt GR; Frazer IH
J Immunol; 2011 Aug; 187(4):1601-8. PubMed ID: 21742969
[TBL] [Abstract][Full Text] [Related]
26. DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection.
Chandra J; Dutton JL; Li B; Woo WP; Xu Y; Tolley LK; Yong M; Wells JW; R Leggatt G; Finlayson N; Frazer IH
J Immunother; 2017; 40(2):62-70. PubMed ID: 28166181
[TBL] [Abstract][Full Text] [Related]
27. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
28. Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38.
Dong W; Kloz U; Accardi R; Caldeira S; Tong WM; Wang ZQ; Jansen L; Dürst M; Sylla BS; Gissmann L; Tommasino M
J Virol; 2005 Dec; 79(23):14899-908. PubMed ID: 16282489
[TBL] [Abstract][Full Text] [Related]
29. Nanobody against the E7 oncoprotein of human papillomavirus 16.
Li S; Zhang W; Jiang K; Shan H; Shi M; Chen B; Hua Z
Mol Immunol; 2019 May; 109():12-19. PubMed ID: 30849663
[TBL] [Abstract][Full Text] [Related]
30. The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles.
Azzimonti B; Dell'oste V; Borgogna C; Mondini M; Gugliesi F; De Andrea M; Chiorino G; Scatolini M; Ghimenti C; Landolfo S; Gariglio M
Virology; 2009 Jun; 388(2):260-9. PubMed ID: 19398117
[TBL] [Abstract][Full Text] [Related]
31. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
32. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
33. Loss of Dependence on Continued Expression of the Human Papillomavirus 16 E7 Oncogene in Cervical Cancers and Precancerous Lesions Arising in Fanconi Anemia Pathway-Deficient Mice.
Park S; Park JW; Pitot HC; Lambert PF
mBio; 2016 May; 7(3):. PubMed ID: 27190216
[TBL] [Abstract][Full Text] [Related]
34. A novel function of HPV16-E6/E7 in epithelial-mesenchymal transition.
Jung YS; Kato I; Kim HR
Biochem Biophys Res Commun; 2013 Jun; 435(3):339-44. PubMed ID: 23628416
[TBL] [Abstract][Full Text] [Related]
35. Oral administration of human papillomavirus type 16 E7 displayed on Lactobacillus casei induces E7-specific antitumor effects in C57/BL6 mice.
Poo H; Pyo HM; Lee TY; Yoon SW; Lee JS; Kim CJ; Sung MH; Lee SH
Int J Cancer; 2006 Oct; 119(7):1702-9. PubMed ID: 16646080
[TBL] [Abstract][Full Text] [Related]
36. HPV16-E7-Specific Activated CD8 T Cells in E7 Transgenic Skin and Skin Grafts.
Jazayeri SD; Kuo PT; Leggatt GR; Frazer IH
Front Immunol; 2017; 8():524. PubMed ID: 28523003
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-17A Promotes Arginase-1 Production and 2,4-Dinitrochlorobenzene-Induced Acute Hyperinflammation in Human Papillomavirus E7 Oncoprotein-Expressing Skin.
Tran le S; Mittal D; Mattarollo SR; Frazer IH
J Innate Immun; 2015; 7(4):392-404. PubMed ID: 25720383
[TBL] [Abstract][Full Text] [Related]
38. GSK3β mediates the carcinogenic effect of HPV16 in cervical cancer.
Ma C; Zeng C; Jin L; Yang Y; Li P; Chen L; Wang J
Sci Rep; 2015 Nov; 5():16555. PubMed ID: 26560046
[TBL] [Abstract][Full Text] [Related]
39. Interferon-gamma enhances cytotoxic T lymphocyte recognition of endogenous peptide in keratinocytes without lowering the requirement for surface peptide.
Leggatt GR; Dunn LA; De Kluyver RL; Stewart T; Frazer IH
Immunol Cell Biol; 2002 Oct; 80(5):415-24. PubMed ID: 12225377
[TBL] [Abstract][Full Text] [Related]
40. A humanized mouse model of HPV-associated pathology driven by E7 expression.
Buitrago-Pérez Á; Hachimi M; Dueñas M; Lloveras B; Santos A; Holguín A; Duarte B; Santiago JL; Akgül B; Rodríguez-Peralto JL; Storey A; Ribas C; Larcher F; del Rio M; Paramio JM; García-Escudero R
PLoS One; 2012; 7(7):e41743. PubMed ID: 22911850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
